Spero Therapeutics launches $100M ATM program with Jefferies
Spero Therapeutics has launched a new at-the-market (ATM) program with Jefferies for up to $100 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.